Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by Atomekon Dec 22, 2016 9:19am

211 Views

Post# 25634235

Short Positions for PLI

Symbol	Report Date	Volume	Change	Shares Issued	% Float
T : PLI	2016-12-15	8,476,240	1,604,658	620,562,340	1.37
T : PLI	2016-11-30	6,871,582	586,497	620,562,340	1.11
T : PLI	2016-11-15	6,285,085	-4,078,696	620,562,340	1.01
T : PLI	2016-10-31	10,363,781	4,234,202	620,562,840	1.67
T : PLI	2016-10-15	6,129,579	926,003	604,817,620	1.01
T : PLI	2016-09-30	5,203,576	-319,905	604,564,308	0.86